Dow Jones

40,211.72

0.53%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

CGEN

Compugen (CGEN)

Compugen Ltd

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CGEN

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 12 13 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
21/03/2022	06:00	PR Newswire (US)	Compugen's Computational Discovery Leverages Single Cell Spatial Transcriptomics to Gain In-Depth Understanding of the Tumor Microenvironment	NASDAQ:CGEN	Compugen Ltd
14/03/2022	06:00	PR Newswire (US)	Compugen To Present New Insights into the Tumor Microenvironment Using Single Cell Spatial Transcriptomics at Keystone Symposium	NASDAQ:CGEN	Compugen Ltd
09/03/2022	06:05	PR Newswire (US)	Compugen to Present at the Oppenheimer 32nd Annual Global Healthcare Conference	NASDAQ:CGEN	Compugen Ltd
09/03/2022	06:00	PR Newswire (US)	Compugen Presents New Research Suggesting Targeting DNAM-1 Axis Holds Promise for Treatment of Multiple Myeloma	NASDAQ:CGEN	Compugen Ltd
28/02/2022	17:10	Edgar (US Regulatory)	Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)	NASDAQ:CGEN	Compugen Ltd
24/02/2022	06:01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CGEN	Compugen Ltd
10/02/2022	06:00	PR Newswire (US)	Compugen to Release Fourth Quarter and Full Year 2021 Results on Thursday, February 24, 2022	NASDAQ:CGEN	Compugen Ltd
09/02/2022	13:27	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CGEN	Compugen Ltd
09/02/2022	06:00	PR Newswire (US)	Compugen to Present at the 11th Annual SVB Leerink Global Healthcare Conference	NASDAQ:CGEN	Compugen Ltd
19/11/2021	15:16	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CGEN	Compugen Ltd
15/11/2021	06:18	TipRanks	Compugen Posts Q3 Loss; Shares Drop 18%	NASDAQ:CGEN	Compugen Ltd
12/11/2021	06:00	PR Newswire (US)	Compugen Reports Third Quarter 2021 Results	NASDAQ:CGEN	Compugen Ltd
11/11/2021	07:29	Dow Jones News	Compugen Shares Rise 18% Premarket After Bristol Myers Investment	NASDAQ:CGEN	Compugen Ltd
26/10/2021	06:00	PR Newswire (US)	Compugen to Release Third Quarter 2021 Results on Friday, November 12, 2021	NASDAQ:CGEN	Compugen Ltd
28/07/2021	06:00	PR Newswire (US)	Compugen Reports Second Quarter 2021 Results	NASDAQ:CGEN	Compugen Ltd
14/07/2021	06:00	PR Newswire (US)	Compugen to Release Second Quarter 2021 Results on Wednesday, July 28, 2021	NASDAQ:CGEN	Compugen Ltd
23/12/2020	06:49	Dow Jones News	Compugen: Preclinical Milestone Met in AstraZeneca Agreement	NASDAQ:CGEN	Compugen Ltd
10/12/2020	15:06	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:CGEN	Compugen Ltd
17/09/2020	07:45	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
30/07/2020	06:19	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:CGEN	Compugen Ltd
12/03/2020	15:39	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:CGEN	Compugen Ltd
24/02/2020	05:47	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:CGEN	Compugen Ltd
12/12/2019	10:35	GlobeNewswire Inc.	Janpix, Inc. Announces Appointment of Sanford (Sandy) Zweifach as Executive Chairman to its Board of Directors	NASDAQ:CGEN	Compugen Ltd
13/08/2019	05:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CGEN	Compugen Ltd
03/06/2019	06:00	PR Newswire (US)	Compugen Presents Update on COM701 Phase 1 Trial at the 2019 ASCO Annual Meeting	NASDAQ:CGEN	Compugen Ltd
30/05/2019	09:19	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:CGEN	Compugen Ltd
22/05/2019	06:00	PR Newswire (US)	Compugen to Present at the Jefferies 2019 Healthcare Conference	NASDAQ:CGEN	Compugen Ltd
20/05/2019	06:05	PR Newswire (US)	Compugen Reports First Quarter 2019 Results	NASDAQ:CGEN	Compugen Ltd
20/05/2019	06:00	PR Newswire (US)	Compugen Doses First Patient in COM701/Opdivo® (Nivolumab) Combination Arm of Phase 1 Study in Patients With Advanced Solid ...	NASDAQ:CGEN	Compugen Ltd
06/05/2019	06:00	PR Newswire (US)	Compugen First Quarter 2019 Conference Call Scheduled for Monday, May 20, 2019 at 8:30 AM ET	NASDAQ:CGEN	Compugen Ltd